Simris Group AB

Simris Group is a biotech company, engaged in research, development and production of bioactive substances from cyanobacteria and microalgae for pharmaceutical applications. At Simris, we are pioneering the next generation of ADC payloads to revolutionise cancer treatment. Our platform is built on the world’s largest cyanobacterial strain library and over two decades of deep scientific expertise. Through our proprietary discovery and bioconjugation technologies, we are developing novel, IP-protected payloads with the potential to dramatically improve both the efficacy and safety of ADC therapeutics. Our headquarters are located in Hammenhög, Sweden. Simris Group AB is a public company and our stock is traded on the Nasdaq First North stock exchange (FNSE:SIMRIS B). http://www.simrisgroup.com http://www.simrisbiologics.com